Motco Bristol Myers Squibb CO Transaction History

Motco

$991 Million
Q3 2024

A detailed history of Motco transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Motco holds 6,774 shares of BMY stock, worth $391,266. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,774

Previous 88,206 92.32%

Holding current value

$391,266

Previous $3.66 Million 90.44%

% of portfolio

0.04%

Previous 0.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$39.66 - $51.75 $3.23 Million - $4.21 Million	-81,432 Reduced 92.32%	6,774 $350,000
Q2 2024 Aug 07, 2024	BUY	$40.25 - $52.99 $287,505 - $378,507	7,143 Added 8.81%	88,206 $3.66 Million
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $31,282 - $35,468	-652 Reduced 0.8%	81,063 $4.4 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $950,498 - $1.13 Million	-19,606 Reduced 19.35%	81,715 $4.19 Million
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $162,902 - $182,150	2,814 Added 2.86%	101,321 $5.88 Million
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $21,597 - $23,980	-339 Reduced 0.34%	98,507 $6.3 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $160,003 - $181,480	2,435 Added 2.53%	98,846 $6.85 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $320,691 - $379,744	-4,683 Reduced 4.63%	96,411 $6.94 Million
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $265 - $156,907	2,042 Added 2.06%	101,094 $7.19 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $1.22 Million - $1.34 Million	-16,763 Reduced 14.47%	99,052 $7.63 Million
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $15,431 - $18,503	-251 Reduced 0.22%	115,815 $8.46 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $244,874 - $285,466	4,566 Added 4.1%	116,066 $7.24 Million
Q3 2021 Oct 29, 2021	BUY	$59.17 - $69.31 $411,231 - $481,704	6,950 Added 6.65%	111,500 $6.6 Million
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $471,568 - $513,538	7,617 Added 7.86%	104,550 $6.99 Million
Q1 2021 Apr 16, 2021	BUY	$59.34 - $66.74 $428,138 - $481,529	7,215 Added 8.04%	96,933 $6.12 Million
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $314,913 - $356,855	-5,454 Reduced 5.73%	89,718 $5.57 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $4.58 Million - $5.07 Million	79,733 Added 516.44%	95,172 $5.74 Million
Q2 2020 Jul 15, 2020	SELL	$54.82 - $64.09 $15,075 - $17,624	-275 Reduced 1.75%	15,439 $908,000
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $5,753 - $8,361	124 Added 0.8%	15,714 $876,000
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $98,961 - $129,086	2,011 Added 14.81%	15,590 $1 Million
Q3 2019 Nov 05, 2019	SELL	$42.77 - $50.71 $19,332 - $22,920	-452 Reduced 3.22%	13,579 $689,000
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $14,769 - $16,331	-331 Reduced 2.3%	14,031 $637,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $95,383 - $113,733	-2,114 Reduced 12.83%	14,362 $685,000
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $2,340 - $3,035	48 Added 0.29%	16,476 $857,000
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $91,946 - $103,708	-1,666 Reduced 9.21%	16,428 $1.02 Million
Q2 2018 Aug 09, 2018	SELL	$50.53 - $62.98 $13,996 - $17,445	-277 Reduced 1.51%	18,094 $1 Million
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $29,360 - $33,800	490 Added 2.74%	18,371 $1.16 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $46,933 - $51,169	-783 Reduced 4.2%	17,881 $1.1 Million
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $71,799 - $82,862	-1,300 Reduced 6.51%	18,664 $1.19 Million
Q2 2017 Aug 08, 2017	BUY	N/A	19,964	19,964 $1.11 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

News

Stay updated on Motco with notifications on news.

Account